Resources with keywords: vaccination



CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised (NEW 11/11, Website, News)
CDC Newsroom
23 October 2024

CDC endorsing that people 65 years and older and those who are moderately or severely immunocompromised receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.

Notes from the Field: Enhanced Surveillance for Raccoon Rabies Virus Variant and Vaccination of Wildlife for Management — Omaha, Nebraska, October 2023–July 2024
CDC / MMWR
17 October 2024

Stein SR, Beron AJ, Nelson KM, et al.
Movement of wildlife has facilitated the spread of non-bat rabies virus variants into new geographic areas of the United States, with major implications for human health.

Prevention Strategies for Mpox, including Vaccinating People at Risk via Sexual Exposure, for U.S. Travelers Visiting Countries with Clade I Mpox Outbreaks
CDC / Health Alert Network (HAN)
23 September 2024

This is a Health Alert Network (HAN) Health Update to provide additional information about the ongoing outbreak of clade I monkeypox virus (MPXV), the virus that causes mpox, in Central and Eastern Africa

Polio Vaccination
CDC
Long COVID Basics (NEW 7/8, Website, Regulatory)
CDC

Discusses the disease, prevention via vaccination, signs and symptoms, complications, testing and diagnosis, who is most at risk, etc.

CDC updates and simplifies respiratory virus recommendations (Website)
CDC
1 March 2024

CDC released updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from a range of common respiratory viral illnesses, such as COVID-19, flu, and RSV.

COVID-19 Vaccine Effectiveness (Website)
CDC / National Center for Immunization and Respiratory Diseases (NCIRD)
1 February 2024

CDC says that updated (2023-2024) COVID-19 vaccines were effective against COVID-19 during September 2023 – January 2024, including against variants from the XBB lineage, which is included in the updated vaccine, and JN.1, a new variant that has become dominant in recent weeks.

Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis
The Lancet
22 January 2024

Schnyder J, et al
The gathered evidence suggests that a single dose of yellow fever vaccination provides lifelong protection in travellers.

Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
CDC / MMWR
8 December 2023

Kidd S, Clark T, Routh J, Cineas S, Bahta L, Brooks O
New recommendations include that adults aged ≥18 years who are known or suspected to be unvaccinated or incompletely vaccinated against polio should complete a primary polio vaccination series with IPV.

When Will the Next COVID Vaccine Be Available, and Who Should Get It? (NEW 9/13, Website)
Scientific American
1 September 2023

Includes info on when the vaccine may be approved and who will benefit most from a booster.

Go to Top